With each passing week of your pregnancy, not only are you discovering new things about your body, but you’re learning about an entirely new world of possibilities for your baby. Did you know that your baby’s umbilical cord blood has the power to save a life? To date, over 35,000 stem cell cord blood transplants have been performed worldwide as a direct result of cord blood banking. Over 80 life threatening illnesses are currently being treated with stem cells, including Leukemia, Lymphoma and Sickle Cell Anemia. Expectant parents are educating themselves on the topic of cord blood and making important decisions that could dictate the future of medicine.
You might be asking, “What is cord blood?”. Cord blood is the blood within your newborn baby’s umbilical cord and the placenta. Inside are young stem cells - the building blocks of the blood and immune system - that can renew themselves and become specialized.
So why cord blood banking? New parents are considering this option because of the future uses of stem cells. These cells can be only harvested right after birth and may be used in therapy or treatment for many different diseases or illnesses within your family. Another way to look at it? These stem cells may be able to cure to some disease or improve the clinical outcome of others.
Join us for a complimentary webinar on Wednesday, November 15th for World Cord Blood Day #WCBD17 and learn directly from the medical experts exactly what cord blood is and why storing it is a crucial step in planning for your family’s future.
The choice to use cord blood stem cells will depend on a variety of factors – only a physician can determine when cord blood stem cells should be used, on a case by case basis. Many of the conditions currently treated with cord blood stem cells are genetic diseases. There is no guarantee that your physician will choose stem cell transplant over other courses of treatment. Unlike cord blood, there are currently no proven treatments using cord tissue stem cells.
Activities for New York State residents are limited to collection of umbilical cord tissue and processing and long-term storage of umbilical cord tissue or cord tissue-derived cells. The tissue bank's possession of a New York State license for such collection, processing and/or long-term storage does not indicate approval or endorsement of possible future uses or future suitability of these cells.